Skip to content

Contract award record

Human Papillomavirus (2025)

Notice details

Published
Category
goods
Buyer region
London

Public buyer and contract winner

awarded to

Contract winner

Merck Sharpe & Dohme (UK) Limited

Award value£1

  1. Awarded
    Completed
  2. Start
    Current phase
  3. End
    Upcoming

Work description

Contract for the supply of human papillomavirus vaccine to be used as part of the national immunisation programme. Deliveries will be required for a four year period from December 2025

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Related awards

Source: Contracts Finder · Notice 05f89446-638f-42a8-b9dd-9a9547feb52d-868412

View source notice